It has been reported that the mutations in DNA2 (Zheng et al., 2020), ACO2 (Sajnani et al., 2017), and ATP7A (Li et al., 2017) were correlated with the initiation or poor clinical outcomes of cancers. Here, DNA2 is linked to cancer.